My first read: CTRL-F for "test" to see if there's any new statement on serological testing. Nothing.
This is all we want right now. This is the first priority, and whatever is second is somewhat distant.
Not having widespread serological testing to understand the prevalence in our communities really gives a feeling of being in a third-world country.
It's awesome that Drs. Bhattacharya and Bendavid have pushed the Stanford study forward (hopefully we have results this week). But seriously, there's no excuse for not having already done a round of random testing in every city, several times.
Serological testing is really bleeding edge still. It’s only done as part of research projects as far as I heard, and you can’t really buy the capacity to do it on an industrial scale yet. Perhaps this varies between countries (where manufacturers exist and so on) but many countries in Europe still have few or no serological tests done, and we are weeks ahead of the US in terms of the epidemic progress.
Yeah, that's the point right there. Why the heck is this so bleeding edge? A small team at Stanford made it happen rather quickly. With a small budget.
And yet our leaders aren't even talking about it. Where's the will to do this obvious first priority?
My first read: CTRL-F for "test" to see if there's any new statement on serological testing. Nothing.
This is all we want right now. This is the first priority, and whatever is second is somewhat distant.
Not having widespread serological testing to understand the prevalence in our communities really gives a feeling of being in a third-world country.
It's awesome that Drs. Bhattacharya and Bendavid have pushed the Stanford study forward (hopefully we have results this week). But seriously, there's no excuse for not having already done a round of random testing in every city, several times.